My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2018/02/07 Council Agenda Packet
>
Council Agenda Packets
>
2018
>
2018/02/07 Council Agenda Packet
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/28/2018 10:49:00 AM
Creation date
2/28/2018 10:46:36 AM
Metadata
Fields
Template:
Council Agenda Packet
Date
2/7/2018
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
445
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Washington State Department of Social and Health Services <br /> Transforming <br /> Behavioral Health Administration Lives <br /> Fact Sheet: Opiate Substitution Treatment Services <br /> Updated: September 19,2016 <br /> Overview Opiate substitution treatment services(OTP) provide a combination of outpatient chemical <br /> dependency counseling along with adjunctive medication reviewed and administered by <br /> medical staff. Each patient is seen by medical staff prior to initially receiving medication. <br /> Upon entry and during treatment, patients receive: <br /> • Chemical dependency diagnostic evaluations. <br /> • Medical screening by medical staff. <br /> • Physical examination by a medical provider. <br /> • Laboratory testing and urine drug screens. <br /> • Medication dose evaluations as needed. <br /> •Weekly counseling for the first three months and monthly thereafter. <br /> Programs must address an array of comprehensive medical, vocational, employment, <br /> legal, and psychological issues, and provide referrals to community-based programs with <br /> expertise to address these issues. Take-home medications are regulated by an eight-point <br /> criteria consisting of length and participation in treatment, results of urine drug screens, <br /> stability in living environment and anti-diversion procedures. <br /> All pregnant patients are provided information about how the medication will affect them <br /> and their fetus prior to the first dose. They are followed by an OB/GYN and the program <br /> physician,who regularly evaluates medications. <br /> Eligibility Patients must meet Diagnostic and Statistical Manual of Mental Disorders (DSM 5) <br /> Requirements diagnostic criteria for opiate dependence and meet state and federal eligibility <br /> requirements for admission. Pregnant and intravenous drug users are priority populations <br /> for admission. <br /> Authority Each agency must be: <br /> • Licensed by the Washington State Department of Health Board of Pharmacy <br /> • Licensed by the federal Drug Enforcement Administration <br /> •Certified by the federal Substance Abuse and Mental Health Services Administration's <br /> Center for Substance Abuse Treatment <br /> • Certified by the Washington State Department of Social and Health Services - Division of <br /> Behavioral Health and Recovery(DBHR) <br /> •Accredited by DBHR or another federally recognized accreditation body <br /> Agencies are regulated through Revised Code of Washington 70.96A, 42 Code of Federal <br /> Washington State <br /> Department of Social <br /> 7 &Health Services <br /> Transforming lives <br /> E?c- Aibtt �� <br />
The URL can be used to link to this page
Your browser does not support the video tag.